Sugarloaf Wealth Management’s Imunon IMNN Stock Holding History

Sugarloaf Wealth Management’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3	Closed	–	–	694
2020 Q1	$0	Buy	3 +1	+50%	+$251	﹤0.01%	712
2019 Q4	$1K	Buy	+2	New	+$607	﹤0.01%	669

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sugarloaf Wealth Management's IMNN Position: Q2 2020 in Review

Sugarloaf Wealth Management sold out of Imunon (IMNN) in Q2 2020, closing a stake of 3 shares.

Sugarloaf Wealth Management first reported a position in IMNN in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q4 2019. 37 funds tracked by Wall St. Rank hold IMNN as of Q2 2020.

Sugarloaf Wealth Management reported no remaining Imunon position as of Q2 2020 after selling out during the quarter.
Sugarloaf Wealth Management sold 3 Imunon shares in Q2 2020.
Sugarloaf Wealth Management first reported a position in Imunon in Q4 2019 and held it in 2 quarters.
Sugarloaf Wealth Management's Imunon position peaked at $1K in Q4 2019.
37 funds tracked by Wall St. Rank held Imunon as of Q2 2020.

Based on Sugarloaf Wealth Management's 13F filing for Q2 2020, filed 21 Jul 2020.